Extension study of the safety and efficacy of CLS-TA for treatment of macular oedema associated with non-infectious uveitis (MAGNOLIA).
Rahul N KhuranaPauline T MerrillSteven YehEric SuhlerMark R BarakatEduardo UchiyamaChristopher Ryan HenryMilan ShahRobert C WangBarry KapikThomas A CiullaPublished in: The British journal of ophthalmology (2021)
Approximately 50% of patients did not require additional treatment for up to 9 months following the last CLS-TA administration.